You just read:

The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead Sciences, Vertex Pharmaceuticals and Nasdaq Biotechnology Index ETF

News provided by

Zacks Investment Research, Inc.

Jan 28, 2013, 09:30 EST